Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

November 01, 1996; Volume 24,Issue 11
  • You have access
    Identification of 2,6-xylidine as a major lidocaine metabolite in human liver slices.
    R J Parker, J M Collins and J M Strong
    Drug Metabolism and Disposition November 1996, 24 (11) 1167-1173;
  • You have access
    Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol.
    J A Lillibridge, T F Kalhorn and J T Slattery
    Drug Metabolism and Disposition November 1996, 24 (11) 1174-1179;
  • You have access
    Improved bacterial expression of the human P form phenolsulfotransferase. Applications to drug metabolism.
    A J Lewis, M M Kelly, U K Walle, E A Eaton, C N Falany and T Walle
    Drug Metabolism and Disposition November 1996, 24 (11) 1180-1185;
  • You have access
    Purification and characterization of rhesus monkey liver amido hydrolases and their roles in the metabolic polymorphism for E6123, a platelet-activating factor receptor antagonist.
    K Kusano, T Seko, S Tanaka, Y Shikata, T Ando, S Ida, M Hosokawa, T Satoh, T Yuzuriha and T Horie
    Drug Metabolism and Disposition November 1996, 24 (11) 1186-1191;
  • You have access
    Acetaminophen-induced hepatotoxicity. Analysis of total covalent binding vs. specific binding to cysteine.
    A M Matthews, D W Roberts, J A Hinson and N R Pumford
    Drug Metabolism and Disposition November 1996, 24 (11) 1192-1196;
  • You have access
    Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver.
    T A Kocarek and A B Reddy
    Drug Metabolism and Disposition November 1996, 24 (11) 1197-1204;
  • You have access
    Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
    S K Roy, R C Moschel and M E Dolan
    Drug Metabolism and Disposition November 1996, 24 (11) 1205-1211;
  • You have access
    Role of human cytochrome P4502A6 in C-oxidation of nicotine.
    M Nakajima, T Yamamoto, K Nunoya, T Yokoi, K Nagashima, K Inoue, Y Funae, N Shimada, T Kamataki and Y Kuroiwa
    Drug Metabolism and Disposition November 1996, 24 (11) 1212-1217;
  • You have access
    Cryopreservation of rat and mouse hepatocytes. I. Comparative viability studies.
    N J Swales, C Luong and J Caldwell
    Drug Metabolism and Disposition November 1996, 24 (11) 1218-1223;
  • You have access
    Cryopreservation of rat and mouse hepatocytes. II. Assessment of metabolic capacity using testosterone metabolism.
    N J Swales, T Johnson and J Caldwell
    Drug Metabolism and Disposition November 1996, 24 (11) 1224-1230;
  • You have access
    Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
    D K Dalvie, N B Khosla, K A Navetta and K E Brighty
    Drug Metabolism and Disposition November 1996, 24 (11) 1231-1240;
  • You have access
    Pharmacokinetics and steady-state tissue distribution of L- and D-isomers of nitroarginine in rats.
    M A Tabrizi-Fard and H L Fung
    Drug Metabolism and Disposition November 1996, 24 (11) 1241-1246;
  • You have access
    Formation of a metabolic intermediate complex of cytochrome P4502B1 by clorgyline.
    U Sharma, E S Roberts and P F Hollenberg
    Drug Metabolism and Disposition November 1996, 24 (11) 1247-1253;
  • You have access
    Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    L Yu and D J Waxman
    Drug Metabolism and Disposition November 1996, 24 (11) 1254-1262;
  • You have access
    Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    T Prueksaritanont, L M Gorham, J D Ellis, C Fernandez-Metzler, P Deluna, J R Gehret, K L Strong, J H Hochman, B C Askew, M E Duggan, J D Gilbert, J H Lin and K P Vyas
    Drug Metabolism and Disposition November 1996, 24 (11) 1263-1271;
  • You have access
    Structural identification of three metabolites and a degradation product of the macrolide immunosuppressant sirolimus (rapamycin) by electrospray-MS/MS after incubation with human liver microsomes.
    F Streit, U Christians, H M Schiebel, A Meyer and K F Sewing
    Drug Metabolism and Disposition November 1996, 24 (11) 1272-1278;
  • You have access
    Excretion of oral 9-cis-retinoic acid in the rat.
    B Disdier, H Bun, M Placidi and A Durand
    Drug Metabolism and Disposition November 1996, 24 (11) 1279-1281;
  • You have access
    Dithionite-supported hydroxylation of palmitic acid by cytochrome P450BM-3.
    X Fang and J R Halpert
    Drug Metabolism and Disposition November 1996, 24 (11) 1282-1285;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 24, Issue 11
1 Nov 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Switch from CAR to PXR in the Presence of EGF
  • Alternative P450 Splicing Redirects Human Drug Metabolism
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics